Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 645681, 6 pages
http://dx.doi.org/10.1155/2014/645681
Research Article

Prognostic Implication of Predominant Histologic Subtypes of Lymph Node Metastases in Surgically Resected Lung Adenocarcinoma

1Division of Thoracic Surgery, Department of Surgery, Kinki University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-sayama 589-8511, Japan
2Division of Molecular Pathology, Department of Pathology, Hyogo College of Medicine, 1-3-6 Minatojima, Chuo-ku, Kobe 650-8530, Japan

Received 19 June 2014; Accepted 27 September 2014; Published 12 October 2014

Academic Editor: Andrea Zanini

Copyright © 2014 Kenichi Suda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, E. Ward, O. Brawley, and A. Jemal, “Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths,” CA Cancer Journal for Clinicians, vol. 61, no. 4, pp. 212–236, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. W. D. Travis, E. Brambilla, H. K. Muller-Hermelink et al., “Pathology and genetics: tumors of the lung, pleura, thymus and heart,” in World Health Organization Classification of Tumors, IARC Press, Lyon, France, 2004. View at Google Scholar
  3. N. Motoi, J. Szoke, G. J. Riely et al., “Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis,” The American Journal of Surgical Pathology, vol. 32, no. 6, pp. 810–827, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. W. D. Travis, E. Brambilla, M. Noguchi et al., “International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma,” Journal of Thoracic Oncology, vol. 6, no. 2, pp. 244–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Warth, T. Muley, M. Meister et al., “The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival,” Journal of Clinical Oncology, vol. 30, no. 13, pp. 1438–1446, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Yoshizawa, N. Motoi, G. J. Riely et al., “Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: Prognostic subgroups and implications for further revision of staging based on analysis of 514 stage i cases,” Modern Pathology, vol. 24, no. 5, pp. 653–664, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. P. A. Russell, Z. Wainer, G. M. Wright, M. Daniels, M. Conron, and R. A. Williams, “Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new international association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary lung adenocarcinoma classification,” Journal of Thoracic Oncology, vol. 6, no. 9, pp. 1496–1504, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. J.-J. Hung, W.-J. Jeng, T.-Y. Chou et al., “Prognostic value of the new international association for the study of lung cancer/American thoracic society/European respiratory society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma,” Annals of Surgery, vol. 258, no. 6, pp. 1079–1086, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. J.-J. Hung, Y.-C. Yeh, W.-J. Jeng et al., “Predictive value of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of lung adenocarcinoma in tumor recurrence and patient survival,” Journal of Clinical Oncology, 2014. View at Publisher · View at Google Scholar
  10. G. Sica, A. Yoshizawa, C. S. Sima et al., “A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage i tumors,” American Journal of Surgical Pathology, vol. 34, no. 8, pp. 1155–1162, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. P. A. Russell, S. A. Barnett, M. Walkiewicz et al., “Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients,” Journal of Thoracic Oncology, vol. 8, no. 4, pp. 461–468, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. J.-P. Pignon, H. Tribodet, G. V. Scagliotti et al., “Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group,” Journal of Clinical Oncology, vol. 26, no. 21, pp. 3552–3559, 2008. View at Publisher · View at Google Scholar · View at Scopus